Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Clinical trial uses small molecule to treat men with incurable prostate cancer

NewYork-Presbyterian and Weill Cornell Medicine have begun the first clinical trial in the United States that uses a small molecule to treat men with progressive prostate cancer that has spread beyond the prostate and is no longer responding to hormonal therapy.

31 May 2017

Study finds opioid dependence and overdose rates after urologic surgery

About 1 in 1,111 patients who undergo urologic surgery for conditions such as prostate cancer and kidney stones experience opioid dependence or overdose (ODO), a Loyola Medicine study has found.

30 May 2017

Prolaris becomes first genetic test to receive Medicare coverage for favorable intermediate and low-risk prostate cancer

Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that Palmetto GBA, a Medicare Administrative Contractor that assesses molecular diagnostic technologies, has issued a positive final Local Coverage Determination to expand Medicare coverage of the Prolaris test.

29 May 2017

FDA approves expanded use of Zykadia for first-line treatment of ALK-positive metastatic NSCLC

Novartis today announced the US Food and Drug Administration approved the expanded use of Zykadia (ceritinib) to include the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive, as detected by an FDA-approved test.

27 May 2017

Lung cancer diagnosis may put patients at greatest risk of suicide, study finds

A lung cancer diagnosis appears to put patients at the greatest risk of suicide when compared to the most common types of non-skin cancers, according to new research presented at the ATS 2017 International Conference.

23 May 2017

Study shows new promise in the fight against pancreatic cancer

New research from the Keck School of Medicine of the University of Southern California shows new promise in the fight against one of the most lethal forms of cancer.

23 May 2017

Study: Educational session effective at reducing distress in prostate cancer patients and female partners

In a recent study, an educational session helped alleviate distress equally in both patients with prostate cancer and their partners.

19 May 2017

DNAe’s article on semiconductor DNA analysis technology placed in Scientific Reports’ top 100 read list for 2016

DNA Electronics, the inventor of semiconductor DNA sequencing technology and developer of a new, revolutionary blood-to-result test for bloodstream infections, announces that an article on research utilizing the Company’s patented semiconductor DNA analysis technology has achieved recognition as one of the top 100 read articles for 2016 in Scientific Reports, a peer reviewed journal from the publishers of Nature.

19 May 2017

Study finds early diagnostic MRI to be cost-effective method for detecting prostate cancer

A diagnostic MRI followed by one of three MRI-guided biopsy strategies is a cost-effective method to detect prostate cancer, according to a new study out of Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center.

17 May 2017

Prototype drug prevents lung cancer tumors in mice by using novel mechanism

Lung cancer tumors were prevented in mice by a novel small molecule that directly activates a tumor suppressor protein.

16 May 2017

New IsoPSA assay detects prostate cancer more precisely than current tests

A team of researchers from Cleveland Clinic, Louis Stokes Cleveland VA Medical Center, Kaiser Permanente Northwest, and other clinical sites have demonstrated that a new blood test known as IsoPSA detects prostate cancer more precisely than current tests in two crucial measures - distinguishing cancer from benign conditions, and identifying patients with high-risk disease.

15 May 2017

Poor environmental quality is linked to increased cancer incidence, say researchers

A new study has demonstrated an association between cancer incidence and poor environmental quality across U.S. counties. In counties where exposure to harmful environmental factors is highest, cancer rates are also highest, particularly the rates of breast cancer and prostate cancer.

9 May 2017

Precise delivery of HDR brachytherapy provides good quality of life to prostate cancer patients

Doctors have found that treating prostate cancer with a single, high dose of radiation delivered precisely to the site of the tumor results in good quality of life and fewer trips to the hospital, with adverse side effects that are no worse than if the radiation treatment had been given in several lower doses.

8 May 2017

Advanced endoscope to enable rapid, accurate diagnosis of early colon cancer

Minimally invasive endoscope using breakthrough photonics technology to enable rapid, accurate diagnosis of bowel polyps and early colon cancer.

5 May 2017

Molecular mechanism reprograms tumor cells to drive treatment resistance in advanced prostate cancer

Columbia University Medical Center researchers have discovered a molecular mechanism that reprograms tumor cells in patients with advanced prostate cancer, reducing their response to anti-androgen therapy.

4 May 2017

New poster presented at ASCB shows power of Phasefocus’ Livecyte label-free cell analysis system

Phasefocus provides a range of products and services based on its proprietary Ptychographic Quantitative Phase Imaging technology to provide a wide range of analytical applications including label-free cell imaging and quantitative electron phase microscopy.

From Phase Focus Limited 4 May 2017

Study finds worse survival rates for heart failure despite advances in treatment

A new analysis finds that, despite advances in care, men and women with a diagnosis of heart failure continue to have worse survival rates than patients with certain common cancers.

4 May 2017

New research uncovers role of mysterious molecule in skin cancer

New research from Sanford Burnham Prebys Medical Discovery Institute (SBP) at Lake Nona uncovers the modus operandi of a mysterious molecule called SPRIGHTLY that has been previously implicated in colorectal cancer, breast cancer, and melanoma.

3 May 2017

Access to prostate cancer treatments in the UK

A major reason for the unmet need in prostate cancer in the UK is the length of time it takes to get new treatments through the reimbursement system with NICE (National Institute for Health and Care Excellence). This has a long-term impact on the UK, making the UK far behind the rest of Europe and even globally in terms of standard of care.

2 May 2017

Study: New gene editing strategy effectively targets cancer-causing ‘fusion genes’ in mouse models

A novel gene therapy using CRISPR genome editing technology effectively targets cancer-causing "fusion genes" and improves survival in mouse models of aggressive liver and prostate cancers, University of Pittsburgh School of Medicine researchers report in a study published online today in Nature Biotechnology.

2 May 2017

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Clinical trial uses small molecule to treat men with incurable prostate cancer

Study finds opioid dependence and overdose rates after urologic surgery

Prolaris becomes first genetic test to receive Medicare coverage for favorable intermediate and low-risk prostate cancer

FDA approves expanded use of Zykadia for first-line treatment of ALK-positive metastatic NSCLC

Lung cancer diagnosis may put patients at greatest risk of suicide, study finds

Study shows new promise in the fight against pancreatic cancer

Study: Educational session effective at reducing distress in prostate cancer patients and female partners

DNAe’s article on semiconductor DNA analysis technology placed in Scientific Reports’ top 100 read list for 2016

Study finds early diagnostic MRI to be cost-effective method for detecting prostate cancer

Prototype drug prevents lung cancer tumors in mice by using novel mechanism

New IsoPSA assay detects prostate cancer more precisely than current tests

Poor environmental quality is linked to increased cancer incidence, say researchers

Precise delivery of HDR brachytherapy provides good quality of life to prostate cancer patients

Advanced endoscope to enable rapid, accurate diagnosis of early colon cancer

Molecular mechanism reprograms tumor cells to drive treatment resistance in advanced prostate cancer

New poster presented at ASCB shows power of Phasefocus’ Livecyte label-free cell analysis system

Study finds worse survival rates for heart failure despite advances in treatment

New research uncovers role of mysterious molecule in skin cancer

Access to prostate cancer treatments in the UK

Study: New gene editing strategy effectively targets cancer-causing ‘fusion genes’ in mouse models

What to know about prostate cancer eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in